BackMineralys Therapeutics Overview

Mineralys Therapeutics Other Current Assets

Mineralys Therapeutics's other current assets is $4.4M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$4.39M
98.12% YoYΔ $-229.09M vs prior year quarter

Peer average / median

Loading

Mineralys Therapeutics Other Current Assets History

Loading

Mineralys Therapeutics vs. peers: Other Current Assets Comparison

Loading

Mineralys Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Mineralys Therapeutics (MLYS) FAQ

As of the most recent data (June 2026), MLYS shows a other current assets of $4.4M. That compares with $230M in the prior-year period — down 98.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MLYS's other current assets is now $4.4M (was $230M) — a 98.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Mineralys Therapeutics is outperforming or lagging.

Tracking MLYS's other current assets over time shows whether Mineralys Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $4.4M That compares with $230M in the prior-year period — down 98.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Mineralys Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $4.4M) with ownership activity and broader fundamentals.